Chemical Component Summary

Name1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-[2-(morpholin-4-yl)ethyl]urea
Identifiers1-[6-[[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]-1,3-benzothiazol-2-yl]-3-(2-morpholin-4-ylethyl)urea
FormulaC25 H23 F N8 O2 S2
Molecular Weight550.631
TypeNON-POLYMER
Isomeric SMILESc1cc(ccc1c2ccc3nnc(n3n2)Sc4ccc5c(c4)sc(n5)NC(=O)NCCN6CCOCC6)F
InChIInChI=1S/C25H23FN8O2S2/c26-17-3-1-16(2-4-17)19-7-8-22-30-31-25(34(22)32-19)37-18-5-6-20-21(15-18)38-24(28-20)29-23(35)27-9-10-33-11-13-36-14-12-33/h1-8,15H,9-14H2,(H2,27,28,29,35)
InChIKeyODIUNTQOXRXOIV-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count61
Chiral Atom Count0
Bond Count66
Aromatic Bond Count26

Drug Info: DrugBank

DrugBank IDDB15382 
NameSAR-125844
Groups investigational
DescriptionSAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors).
SynonymsSAR-125844
Categories
  • Amides
  • Heterocyclic Compounds, Fused-Ring
  • Sulfur Compounds
  • Thiazoles
CAS number1116743-46-4

Related Resource References

Resource NameReference
PubChem 25182860